“…Further modifications and optimizations gener- ated more membrane-permeable and PDE-resistant EPACspecific agonists (838,1075). While these 2'-O-alkyl-based cAMP analogs have been widely employed as pharmacological tools to probe EPAC-specific functions (191,290,451,627), extensive studies also document that these EPACspecific cAMP analogs, as well as their cellular metabolites, display activity towards multiple cellular targets, thereby leading to cross-target activities and off-target effects (275-277, 413, 414, 624, 838, 902). These findings raise significant concerns over the specificity of 8-CPT-cAMP analogs as cAMP mimetics and the applications of 8-CPT-2'-O-Me-cAMP class compounds as EPAC selective activators.…”